Archive | Evercyte GmbH
Evercyte partners with AIM Biotech for microfluidic immortalized cell lines
Tuesday 29th October 2024
Learn More >
Evercyte adds telomerized perinatal cells to immortalized range
Tuesday 8th October 2024
Learn More >
Evercyte P-EP/SVTERT344 telomerized amniotic epithelial cells from placenta
Thursday 8th August 2024
Learn More >
Evercyte teams with Phoenestra and TAmiRNA to offer EVs at scale
Tuesday 23rd April 2024
Learn More >
Evercyte contributing to reduced animal testing at key events
Thursday 30th November 2023
Learn More >
Evercyte promoting telomerized cell advantages at Small New World symposium
Thursday 24th August 2023
Learn More >
Evercyte immortalized cell lines compatible with OOAC organ on chip technology
Wednesday 2nd August 2023
Learn More >
Evercyte EVs from human bone marrow-derived MSC (EV-BM-MSC/TERT292)
Tuesday 11th July 2023
Learn More >
Evercyte brings EV and senescent cell expertise to EU Horizon CHANGE project
Friday 28th April 2023
Learn More >